Cronos Group (TSE:CRON) Stock Price Down 6.8% - Time to Sell?

Key Points

• Cronos Group Inc. stock fell by 6.8%, reaching a low of C$3.80 during trading, with a significant increase in trading volume of 125% compared to the average session.
• The company has a market capitalization of C$1.47 billion and is characterized by a high price-to-earnings ratio of 77.00.
• Cronos Group, based in Toronto, primarily operates in Canada but also exports medical cannabis internationally and has established joint ventures in Israel, Colombia, and Australia.

Cronos Group Inc. (TSE:CRON - ) shares traded down 6.8% during mid-day trading on Tuesday . The stock traded as low as C$3.80 and last traded at C$3.85. 430,848 shares were traded during trading, an increase of 125% from the average session volume of 191,806 shares. The stock had previously closed at C$4.13.

Cronos Group Stock Performance

The stock has a market cap of C$1.47 billion, a price-to-earnings ratio of 77.00, a price-to-earnings-growth ratio of 0.12 and a beta of 1.21. The company has a debt-to-equity ratio of 0.17, a current ratio of 24.24 and a quick ratio of 24.01. The stock's 50-day moving average is C$3.38 and its 200-day moving average is C$2.90.

Cronos Group Company Profile

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.